These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 12200600)
1. Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice. Dabrowska-Iwanicka A; Olszewska D; Jalili A; Makowski M; Grzela T; Marczak M; Hoser G; Giermasz A; Golab J; Jakóbisiak M J Cancer Res Clin Oncol; 2002 Aug; 128(8):433-42. PubMed ID: 12200600 [TBL] [Abstract][Full Text] [Related]
2. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice. Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide. Wietrzyk J; Boratynski J; Grynkiewicz G; Ryczynski A; Radzikowski C; Opolski A Anticancer Res; 2001; 21(6A):3893-6. PubMed ID: 11911265 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer]. Fan YF; Huang ZH; Nie J Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739 [TBL] [Abstract][Full Text] [Related]
5. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model. Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694 [TBL] [Abstract][Full Text] [Related]
6. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice. Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375 [TBL] [Abstract][Full Text] [Related]
7. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy. Muramaki M; Miyake H; Hara I; Kamidono S Clin Cancer Res; 2003 Nov; 9(14):5152-60. PubMed ID: 14613994 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models. Herbst RS; Takeuchi H; Teicher BA Cancer Chemother Pharmacol; 1998; 41(6):497-504. PubMed ID: 9554595 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335 [TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor effect of an angiogenesis inhibitor (TNP-470) and tumor necrosis factor in mice. Amikura K; Matsuno S; Egawa S Surg Today; 2006; 36(12):1069-74. PubMed ID: 17123135 [TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Tanaka T; Konno H; Matsuda I; Nakamura S; Baba S Cancer Res; 1995 Feb; 55(4):836-9. PubMed ID: 7531615 [TBL] [Abstract][Full Text] [Related]
12. "Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies. Rybak SM; Sanovich E; Hollingshead MG; Borgel SD; Newton DL; Melillo G; Kong D; Kaur G; Sausville EA Cancer Res; 2003 Jun; 63(11):2812-9. PubMed ID: 12782586 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T Clin Cancer Res; 2003 Feb; 9(2):886-99. PubMed ID: 12576464 [TBL] [Abstract][Full Text] [Related]
14. Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism. Mauriz JL; Gonzalez P; Duran MC; Molpeceres V; Culebras JM; Gonzalez-Gallego J Transl Res; 2007 Jan; 149(1):46-53. PubMed ID: 17196522 [TBL] [Abstract][Full Text] [Related]
15. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Kato T; Sato K; Kakinuma H; Matsuda Y Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. Lund EL; Bastholm L; Kristjansen PE Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723 [TBL] [Abstract][Full Text] [Related]
17. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model. Zagozdzon R; Stokłosa T; Gołab J; Giermasz A; Dabrowska A; Lasek W; Jakóbisiak M Anticancer Res; 1997; 17(6D):4493-8. PubMed ID: 9494557 [TBL] [Abstract][Full Text] [Related]
18. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma. Morita T; Shinohara N; Tokue A Br J Urol; 1994 Oct; 74(4):416-21. PubMed ID: 7529632 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice. Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of radiation response by combined treatment with angiogenesis inhibitor, TNP-470, in oral squamous cell carcinoma. Shintani S; Li C; Mihara M; Klosek SK; Terakado N; Hino S; Hamakawa H Oral Oncol; 2006 Jan; 42(1):66-72. PubMed ID: 16140034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]